Mpox has made a concerning comeback, compelling immediate and collaborative action. With an increased threat from the Clade Ib strain, the situation demands an effective response framework modeled after successful strategies used in the COVID-19 pandemic. This involves substantial input from both
The clinical research landscape is on the cusp of a transformative shift with the U.S. Food and Drug Administration (FDA) poised to implement a groundbreaking regulation by May 2025. This regulation mandates the use of a single, centralized institutional review board (sIRB) for multisite trials,
Uganda’s Leader of Opposition, Joel Ssenyonyi, alongside a group of 15 other Members of Parliament, recently conducted an insightful inspection of the Dei BioPharma facility located in Matugga. This visit, which took place on September 19, 2024, marked a significant milestone that underscored the f
Kaida BioPharma, an emerging pharmaceutical company based in Fort Lauderdale, Florida, has announced the launch of its new corporate social media channels. This significant development aims to enhance the company’s presence across various platforms, including X, LinkedIn, and Facebook. By l
In a significant move likely to reshape the competitive landscape, the FDA has granted approval for Novartis’ Kisqali, when paired with an aromatase inhibitor, for the adjuvant treatment of HR-positive, HER2-negative stage 2 and 3 breast cancer at high risk of recurrence post-surgery. This approval
GC Therapeutics (GCTx), a biotech company founded in 2019, has captured the spotlight with its pioneering approach to cell therapy. With a mission centered on advanced induced pluripotent stem cell (iPSC)-based medicines, GCTx is driven by its innovative TFome platform. Bolstered by a successful
